Monocyte heterogeneity in human cardiovascular disease

Immunobiology

Volumn 217, Issue 12, 2012, Pages 1273-1284

  Zawada, Adam M ^a   Rogacev, Kyrill S ^a   Schirmer, Stephan H ^a   Sester, Martina ^a   Böhm, Michael ^a   Fliser, Danilo ^a   Heine, Gunnar H ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Cardiovascular disease; CD14; CD16; Monocyte heterogeneity

Indexed keywords

ANGIOTENSIN II; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HLA DR ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; P SELECTIN GLYCOPROTEIN LIGAND 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL COUNT; CELL HETEROGENEITY; CELLULAR DISTRIBUTION; CHRONIC KIDNEY DISEASE; CYTOCHEMISTRY; DRUG TARGETING; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; OBESITY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; SPECIES DIFFERENCE;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MONOCYTES;

EID: 84869087599     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.001     Document Type: Article

References (115)

1. Alamanda V., Singh S., Lawrence N.J., Chellappan S.P. Nicotine-mediated induction of E-selectin in aortic endothelial cells requires Src kinase and E2F1 transcriptional activity. Biochem. Biophys. Res. Commun. 2012, 418:56-61.
2. Alvarez A., Cerda-Nicolas M., Naim Abu Nabah Y., Mata M., Issekutz A.C., Panes J., Lobb R.R., Sanz M.J. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 2004, 104:402-408.
3. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., Gabuzda D. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 2003, 197:1701-1707.
4. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., Sarnacki S., Cumano A., Lauvau G., Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
5. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
6. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 2002, 168:3536-3542.
7. Berg K.E., Ljungcrantz I., Andersson L., Bryngelsson C., Hedblad B., Fredrikson G.N., Nilsson J., Bjorkbacka H. Elevated CD14++ CD16- monocytes predict cardiovascular events. Circ. Cardiovasc. Genet. 2012, 5:122-131.
8. Brauner A., Lu Y., Hallden G., Hylander B., Lundahl J. Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity. Inflammation 1998, 22:55-66.
9. Carracedo J., Merino A., Nogueras S., Carretero D., Berdud I., Ramirez R., Tetta C., Rodriguez M., Martin-Malo A., Aljama P. On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J. Am. Soc. Nephrol. 2006, 17:2315-2321.
10. Coen P.M., Flynn M.G., Markofski M.M., Pence B.D., Hannemann R.E. Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population. Metabolism 2010, 59:1775-1783.
11. Cottam D.R., Schaefer P.A., Shaftan G.W., Velcu L., Angus L.D. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes. Surg. 2002, 12:335-342.
12. Cros J., Cagnard N., Woollard K., Patey N., Zhang S.Y., Senechal B., Puel A., Biswas S.K., Moshous D., Picard C., Jais J.P., D'Cruz D., Casanova J.L., Trouillet C., Geissmann F. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33:375-386.
13. de Jager D.J., Grootendorst D.C., Jager K.J., van Dijk P.C., Tomas L.M., Ansell D., Collart F., Finne P., Heaf J.G., De Meester J., Wetzels J.F., Rosendaal F.R., Dekker F.W. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009, 302:1782-1789.
14. Draude G., von Hundelshausen P., Frankenberger M., Ziegler-Heitbrock H.W., Weber C. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset. Am. J. Physiol. 1999, 276:H1144-H1149.
15. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
16. Eriksson E.E., Werr J., Guo Y., Thoren P., Lindbom L. Direct observations in vivo on the role of endothelial selectins and alpha(4) integrin in cytokine-induced leukocyte-endothelium interactions in the mouse aorta. Circ. Res. 2000, 86:526-533.
17. Fingerle G., Pforte A., Passlick B., Blumenstein M., Strobel M., Ziegler-Heitbrock H.W. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993, 82:3170-3176.
18. Fuster V., Moreno P.R., Fayad Z.A., Corti R., Badimon J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J. Am. Coll. Cardiol. 2005, 46:937-954.
19. Gautier E.L., Jakubzick C., Randolph G.J. Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1412-1418.
20. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
21. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004, 351:1296-1305.
22. Gonzalez P., Alvarez R., Batalla A., Reguero J.R., Alvarez V., Astudillo A., Cubero G.I., Cortina A., Coto E. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun. 2001, 2:191-195.
23. Grau A.J., Boddy A.W., Dukovic D.A., Buggle F., Lichy C., Brandt T., Hacke W. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 2004, 35:1147-1152.
24. Greaves D.R., Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 2009, 50(Suppl.):S282-S286.
25. Grip O., Bredberg A., Lindgren S., Henriksson G. Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm. Bowel Dis. 2007, 13:566-572.
26. Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011, 12:204-212.
27. Heimbeck I., Hofer T.P., Eder C., Wright A.K., Frankenberger M., Marei A., Boghdadi G., Scherberich J., Ziegler-Heitbrock L. Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A 2010, 77:823-830.
28. Heine G.H., Ortiz A., Massy Z.A., Lindholm B., Wiecek A., Martinez-Castelao A., Covic A., Goldsmith D., Suleymanlar G., London G.M., Parati G., Sicari R., Zoccali C., Fliser D. Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat. Rev. Nephrol. 2012, 8:362-369.
29. Heine G.H., Ulrich C., Seibert E., Seiler S., Marell J., Reichart B., Krause M., Schlitt A., Kohler H., Girndt M. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int. 2008, 73:622-629.
30. Horelt A., Belge K.U., Steppich B., Prinz J., Ziegler-Heitbrock L. The CD14+CD16+ monocytes in erysipelas are expanded and show reduced cytokine production. Eur. J. Immunol. 2002, 32:1319-1327.
31. Huo Y., Hafezi-Moghadam A., Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 2000, 87:153-159.
32. Imanishi T., Ikejima H., Tsujioka H., Kuroi A., Ishibashi K., Komukai K., Tanimoto T., Ino Y., Takeshita T., Akasaka T. Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis 2010, 212:628-635.
33. Ingersoll M.A., Spanbroek R., Lottaz C., Gautier E.L., Frankenberger M., Hoffmann R., Lang R., Haniffa M., Collin M., Tacke F., Habenicht A.J., Ziegler-Heitbrock L., Randolph G.J. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010, 115:e10-e19.
34. Johnsen S.H., Fosse E., Joakimsen O., Mathiesen E.B., Stensland-Bugge E., Njolstad I., Arnesen E. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromso Study. Stroke 2005, 36:715-719.
35. Kapinsky M., Torzewski M., Buchler C., Duong C.Q., Rothe G., Schmitz G. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1004-1010.
36. Kashiwagi M., Imanishi T., Tsujioka H., Ikejima H., Kuroi A., Ozaki Y., Ishibashi K., Komukai K., Tanimoto T., Ino Y., Kitabata H., Hirata K., Akasaka T. Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010, 212:171-176.
37. Katayama K., Matsubara T., Fujiwara M., Koga M., Furukawa S. CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin. Exp. Immunol. 2000, 121:566-570.
38. Kawanaka N., Nagake Y., Yamamura M., Makino H. Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure. Nephron 2002, 90:64-71.
39. Kawanaka N., Yamamura M., Aita T., Morita Y., Okamoto A., Kawashima M., Iwahashi M., Ueno A., Ohmoto Y., Makino H. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002, 46:2578-2586.
40. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002, 277:49982-49988.
41. Landsman L., Bar-On L., Zernecke A., Kim K.W., Krauthgamer R., Shagdarsuren E., Lira S.A., Weissman I.L., Weber C., Jung S. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009, 113:963-972.
42. Lenart M., Trzyna E., Rutkowska M., Bukowska-Strakova K., Szaflarska A., Pituch-Noworolska A., Szczepanik A., Zembala M., Siedlar M. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism. Int. J. Mol. Med. 2010, 26:435-442.
43. Ley K., Miller Y.I., Hedrick C.C. Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1506-1516.
44. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
45. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
46. Liu Y., Imanishi T., Ikejima H., Tsujioka H., Ozaki Y., Kuroi A., Okochi K., Ishibashi K., Tanimoto T., Ino Y., Kitabata H., Akasaka T. Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction. Circ. J. 2010, 74:2585-2591.
47. Manning-Tobin J.J., Moore K.J., Seimon T.A., Bell S.A., Sharuk M., Alvarez-Leite J.I., de Winther M.P., Tabas I., Freeman M.W. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler. Thromb. Vasc. Biol. 2009, 29:19-26.
48. Mehta N.N., Reilly M.P. Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes?. Circ. Cardiovasc. Genet. 2012, 5:7-9.
49. Merino A., Buendia P., Martin-Malo A., Aljama P., Ramirez R., Carracedo J. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J. Immunol. 2011, 186:1809-1815.
50. Mestas J., Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc. Med. 2008, 18:228-232.
51. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 2003, 278:1561-1568.
52. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., McKee M., Freeman M.W. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 2005, 115:2192-2201.
53. Mosig S., Rennert K., Krause S., Kzhyshkowska J., Neunubel K., Heller R., Funke H. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J. 2009, 23:866-874.
54. Muller W.A. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 2003, 24:327-334.
55. Muntinghe F.L., Verduijn M., Zuurman M.W., Grootendorst D.C., Carrero J.J., Qureshi A.R., Luttropp K., Nordfors L., Lindholm B., Brandenburg V., Schalling M., Stenvinkel P., Boeschoten E.W., Krediet R.T., Navis G., Dekker F.W. CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J. Am. Soc. Nephrol. 2009, 20:1641-1649.
56. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study. Lancet 1997, 349:1498-1504.
57. Nahrendorf M., Pittet M.J., Swirski F.K. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010, 121:2437-2445.
58. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 2005, 85:1-31.
59. Nockher W.A., Scherberich J.E. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect. Immun. 1998, 66:2782-2790.
60. Nockher W.A., Wiemer J., Scherberich J.E. Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets. Clin. Exp. Immunol. 2001, 123:49-55.
61. Ozaki Y., Imanishi T., Tanimoto T., Kashiwagi M., Tsujioka H., Sougawa H., Orii M., Shiono Y., Shimamura K., Ishibashi K., Komukai K., Ino Y., Kitabata H., Akasaka T. Effect of direct Renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction. Circ. J. 2012, 76:1461-1468.
62. Pai J.K., Kraft P., Cannuscio C.C., Manson J.E., Rexrode K.M., Albert C.M., Hunter D., Rimm E.B. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women. Atherosclerosis 2006, 186:132-139.
63. Passlick B., Flieger D., Ziegler-Heitbrock H.W. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989, 74:2527-2534.
64. Poitou C., Dalmas E., Renovato M., Benhamo V., Hajduch F., Abdennour M., Kahn J.F., Veyrie N., Rizkalla S., Fridman W.H., Sautes-Fridman C., Clement K., Cremer I. CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2322-2330.
65. Qu C., Edwards E.W., Tacke F., Angeli V., Llodra J., Sanchez-Schmitz G., Garin A., Haque N.S., Peters W., van Rooijen N., Sanchez-Torres C., Bromberg J., Charo I.F., Jung S., Lira S.A., Randolph G.J. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J. Exp. Med. 2004, 200:1231-1241.
66. Ramirez R., Carracedo J., Soriano S., Jimenez R., Martin-Malo A., Rodriguez M., Blasco M., Aljama P. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am. J. Kidney Dis. 2005, 45:353-359.
67. Riou S., Mees B., Esposito B., Merval R., Vilar J., Stengel D., Ninio E., van Haperen R., de Crom R., Tedgui A., Lehoux S. High pressure promotes monocyte adhesion to the vascular wall. Circ. Res. 2007, 100:1226-1233.
68. Rocha V.Z., Libby P. Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 2009, 6:399-409.
69. Rogacev K.S., Heine G.H. Human monocyte heterogeneity - a nephrological perspective. Nephrol. Ther. 2010, 6:219-225.
70. Rogacev K.S., Seiler S., Zawada A.M., Reichart B., Herath E., Roth D., Ulrich C., Fliser D., Heine G.H. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur. Heart J. 2011, 32:84-92.
71. Rogacev K.S., Ulrich C., Blomer L., Hornof F., Oster K., Ziegelin M., Cremers B., Grenner Y., Geisel J., Schlitt A., Kohler H., Fliser D., Girndt M., Heine G.H. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur. Heart J. 2010, 31:369-376.
72. Rogacev K.S., Ziegelin M., Ulrich C., Seiler S., Girndt M., Fliser D., Heine G.H. Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. Nephrol. Dial. Transplant. 2009, 24:3480-3486.
73. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
74. Rossol M., Kraus S., Pierer M., Baerwald C., Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes Th17 expansion. Arthritis Rheum. 2011, 64:671-677.
75. Rothe G., Gabriel H., Kovacs E., Klucken J., Stohr J., Kindermann W., Schmitz G. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 1996, 16:1437-1447.
76. Rothe G., Herr A.S., Stohr J., Abletshauser C., Weidinger G., Schmitz G. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease. Atherosclerosis 1999, 144:251-261.
77. Saleh M.N., Goldman S.J., LoBuglio A.F., Beall A.C., Sabio H., McCord M.C., Minasian L., Alpaugh R.K., Weiner L.M., Munn D.H. CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 1995, 85:2910-2917.
78. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., McCullough P.A., Kasiske B.L., Kelepouris E., Klag M.J., Parfrey P., Pfeffer M., Raij L., Spinosa D.J., Wilson P.W. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
79. Schlitt A., Heine G.H., Blankenberg S., Espinola-Klein C., Dopheide J.F., Bickel C., Lackner K.J., Iz M., Meyer J., Darius H., Rupprecht H.J. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb. Haemost. 2004, 92:419-424.
80. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
81. Seimon T.A., Nadolski M.J., Liao X., Magallon J., Nguyen M., Feric N.T., Koschinsky M.L., Harkewicz R., Witztum J.L., Tsimikas S., Golenbock D., Moore K.J., Tabas I. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010, 12:467-482.
82. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 2006, 7:311-317.
83. Sester U., Sester M., Heine G., Kaul H., Girndt M., Kohler H. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol. Dial. Transplant. 2001, 16:1402-1408.
84. Shantsila E., Wrigley B., Tapp L., Apostolakis S., Montoro-Garcia S., Drayson M.T., Lip G.Y. Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J. Thromb. Haemost. 2011, 9:1056-1066.
85. Soares G., Barral A., Costa J.M., Barral-Netto M., Van Weyenbergh J. CD16+ monocytes in human cutaneous leishmaniasis: increased ex vivo levels and correlation with clinical data. J. Leukoc. Biol. 2006, 79:36-39.
86. Steppich B., Dayyani F., Gruber R., Lorenz R., Mack M., Ziegler-Heitbrock H.W. Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am. J. Physiol. Cell Physiol. 2000, 279:C578-C586.
87. Stohr J., Schindler G., Rothe G., Schmitz G. Enhanced upregulation of the Fc gamma receptor IIIa (CD16a) during in vitro differentiation of ApoE4/4 monocytes. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1424-1432.
88. Strauss-Ayali D., Conrad S.M., Mosser D.M. Monocyte subpopulations and their differentiation patterns during infection. J. Leukoc. Biol. 2007, 82:244-252.
89. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., Leenen P.J. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004, 172:4410-4417.
90. Swirski F.K., Libby P., Aikawa E., Alcaide P., Luscinskas F.W., Weissleder R., Pittet M.J. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 2007, 117:195-205.
91. Swirski F.K., Weissleder R., Pittet M.J. Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1424-1432.
92. Szaflarska A., Baj-Krzyworzeka M., Siedlar M., Weglarczyk K., Ruggiero I., Hajto B., Zembala M. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp. Hematol. 2004, 32:748-755.
93. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., Garin A., Liu J., Mack M., van Rooijen N., Lira S.A., Habenicht A.J., Randolph G.J. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 2007, 117:185-194.
94. Tallone T., Turconi G., Soldati G., Pedrazzini G., Moccetti T., Vassalli G. Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets. J. Cardiovasc. Transl. Res. 2011, 4:211-219.
95. Tapp L.D., Shantsila E., Wrigley B.J., Pamukcu B., Lip G.Y. The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J. Thromb. Haemost. 2012, 10:1231-1241.
96. Thieblemont N., Weiss L., Sadeghi H.M., Estcourt C., Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 1995, 25:3418-3424.
97. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 2007, 117:902-909.
98. Tsujioka H., Imanishi T., Ikejima H., Kuroi A., Takarada S., Tanimoto T., Kitabata H., Okochi K., Arita Y., Ishibashi K., Komukai K., Kataiwa H., Nakamura N., Hirata K., Tanaka A., Akasaka T. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J. Am. Coll. Cardiol. 2009, 54:130-138.
99. Tsujioka H., Imanishi T., Ikejima H., Tanimoto T., Kuroi A., Kashiwagi M., Okochi K., Ishibashi K., Komukai K., Ino Y., Kitabata H., Akasaka T. Post-reperfusion enhancement of CD14(+)CD16(-) monocytes and microvascular obstruction in ST-segment elevation acute myocardial infarction. Circ. J. 2010, 74:1175-1182.
100. Ulrich C., Heine G.H., Garcia P., Reichart B., Georg T., Krause M., Kohler H., Girndt M. Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease. Nephrol. Dial. Transplant. 2006, 21:1596-1602.
101. Ulrich C., Heine G.H., Gerhart M.K., Kohler H., Girndt M. Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am. J. Transplant. 2008, 8:103-110.
102. Ulrich C., Heine G.H., Seibert E., Fliser D., Girndt M. Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2010, 25:2265-2272.
103. Ulrich C., Seibert E., Heine G.H., Fliser D., Girndt M. Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2011, 6:505-511.
104. Urra X., Villamor N., Amaro S., Gomez-Choco M., Obach V., Oleaga L., Planas A.M., Chamorro A. Monocyte subtypes predict clinical course and prognosis in human stroke. J. Cereb. Blood Flow Metab. 2009, 29:994-1002.
105. van der Laan A.M., Hirsch A., Robbers L.F., Nijveldt R., Lommerse I., Delewi R., van der Vleuten P.A., Biemond B.J., Zwaginga J.J., van der Giessen W.J., Zijlstra F., van Rossum A.C., Voermans C., van der Schoot C.E., Piek J.J. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am. Heart J. 2012, 163:57-65. e2.
106. Wang S., Peng Q., Zhang J., Liu L. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc. Res. 2008, 80:255-262.
107. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 2008, 8:802-815.
108. Weiner L.M., Li W., Holmes M., Catalano R.B., Dovnarsky M., Padavic K., Alpaugh R.K. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res. 1994, 54:4084-4090.
109. Wheeler J.G., Mussolino M.E., Gillum R.F., Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur. Heart J. 2004, 25:1287-1292.
110. Wildgruber M., Lee H., Chudnovskiy A., Yoon T.J., Etzrodt M., Pittet M.J., Nahrendorf M., Croce K., Libby P., Weissleder R., Swirski F.K. Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors. PLoS One 2009, 4:e5663.
111. Wong K.L., Tai J.J., Wong W.C., Han H., Sem X., Yeap W.H., Kourilsky P., Wong S.C. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
112. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 2010, 7:77-86.
113. Zawada A.M., Rogacev K.S., Rotter B., Winter P., Marell R.R., Fliser D., Heine G.H. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011, 118:e50-e61.
114. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1897-1908.
115. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., MacPherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.